Table of Content

1 Nuclear Medicine & Radiopharmaceuticals Market Overview
1.1 Nuclear Medicine & Radiopharmaceuticals Product Scope
1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Price Trends (2016-2027)

2 Nuclear Medicine & Radiopharmaceuticals Estimates and Forecasts by Region
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2021)
2.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
2.3 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.3 China Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.4 Japan Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.6 India Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2016-2027)
3 Global Nuclear Medicine & Radiopharmaceuticals Competition Landscape by Players
3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Players by Sales (2016-2021)
3.2 Global Top Nuclear Medicine & Radiopharmaceuticals Players by Revenue (2016-2021)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2020)
3.4 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Company (2016-2021)
3.5 Manufacturers Nuclear Medicine & Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type
4.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2021)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application
5.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2021)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures
6.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Company
6.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
6.1.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
6.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
6.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
6.2.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
6.3 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
6.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
6.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures
7.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Company
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
7.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
7.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures
8.1 China Nuclear Medicine & Radiopharmaceuticals Sales by Company
8.1.1 China Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
8.1.2 China Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
8.2 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
8.2.1 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
8.2.2 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
8.3 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures
9.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales by Company
9.1.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
9.1.2 Japan Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
9.2 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
9.2.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
9.2.2 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
9.3 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures
10.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Company
10.1.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
10.1.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
10.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
10.2.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures
11.1 India Nuclear Medicine & Radiopharmaceuticals Sales by Company
11.1.1 India Nuclear Medicine & Radiopharmaceuticals Sales by Company (2016-2021)
11.1.2 India Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021)
11.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
11.2.1 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
11.2.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
11.3 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application
11.3.1 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
11.3.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nuclear Medicine & Radiopharmaceuticals Business
12.1 China Isotope & Radiation
12.1.1 China Isotope & Radiation Corporation Information
12.1.2 China Isotope & Radiation Business Overview
12.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
12.1.5 China Isotope & Radiation Recent Development
12.2 Dongcheng
12.2.1 Dongcheng Corporation Information
12.2.2 Dongcheng Business Overview
12.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Products Offered
12.2.5 Dongcheng Recent Development
12.3 Jaco
12.3.1 Jaco Corporation Information
12.3.2 Jaco Business Overview
12.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Products Offered
12.3.5 Jaco Recent Development
12.4 Ciaeriar
12.4.1 Ciaeriar Corporation Information
12.4.2 Ciaeriar Business Overview
12.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Products Offered
12.4.5 Ciaeriar Recent Development
12.5 Advanced Molecular-imaging Solution
12.5.1 Advanced Molecular-imaging Solution Corporation Information
12.5.2 Advanced Molecular-imaging Solution Business Overview
12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Products Offered
12.5.5 Advanced Molecular-imaging Solution Recent Development
12.6 Shanghai Atom Kexing
12.6.1 Shanghai Atom Kexing Corporation Information
12.6.2 Shanghai Atom Kexing Business Overview
12.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Products Offered
12.6.5 Shanghai Atom Kexing Recent Development
...

13 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Analysis
13.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
13.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nuclear Medicine & Radiopharmaceuticals Distributors List
14.3 Nuclear Medicine & Radiopharmaceuticals Customers

15 Market Dynamics
15.1 Nuclear Medicine & Radiopharmaceuticals Market Trends
15.2 Nuclear Medicine & Radiopharmaceuticals Drivers
15.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges
15.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Region (2016-2021)
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Region (2016-2021)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share Forecast by Region (2022-2027)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Company (2016-2021)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Company (2016-2021)
Table 16. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2020)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Nuclear Medicine & Radiopharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 22. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2022-2027)
Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2016-2021)
Table 33. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2022-2027)
Table 34. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 35. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 37. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2022-2027)
Table 38. North America Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 39. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 40. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 42. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 43. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 44. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 45. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 46. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 47. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 48. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 49. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 50. Europe Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 51. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 54. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 55. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 56. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 57. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 58. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 59. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 61. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 62. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 63. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 64. China Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 66. China Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 67. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 68. China Nuclear Medicine & Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 69. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 70. China Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 71. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 72. China Nuclear Medicine & Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 73. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 74. Japan Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 75. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 76. Japan Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 78. Japan Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 79. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 80. Japan Nuclear Medicine & Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 81. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 82. Japan Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 83. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 84. Japan Nuclear Medicine & Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 85. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 98. India Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 99. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 100. India Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 102. India Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 103. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 104. India Nuclear Medicine & Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 105. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 106. India Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 107. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 108. India Nuclear Medicine & Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 109. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 110. China Isotope & Radiation Corporation Information
Table 111. China Isotope & Radiation Description and Business Overview
Table 112. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product
Table 114. China Isotope & Radiation Recent Development
Table 115. Dongcheng Corporation Information
Table 116. Dongcheng Description and Business Overview
Table 117. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product
Table 119. Dongcheng Recent Development
Table 120. Jaco Corporation Information
Table 121. Jaco Description and Business Overview
Table 122. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Jaco Nuclear Medicine & Radiopharmaceuticals Product
Table 124. Jaco Recent Development
Table 125. Ciaeriar Corporation Information
Table 126. Ciaeriar Description and Business Overview
Table 127. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product
Table 129. Ciaeriar Recent Development
Table 130. Advanced Molecular-imaging Solution Corporation Information
Table 131. Advanced Molecular-imaging Solution Description and Business Overview
Table 132. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product
Table 134. Advanced Molecular-imaging Solution Recent Development
Table 135. Shanghai Atom Kexing Corporation Information
Table 136. Shanghai Atom Kexing Description and Business Overview
Table 137. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product
Table 139. Shanghai Atom Kexing Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 143. Nuclear Medicine & Radiopharmaceuticals Customers List
Table 144. Nuclear Medicine & Radiopharmaceuticals Market Trends
Table 145. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Table 146. Nuclear Medicine & Radiopharmaceuticals Market Challenges
Table 147. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Thyroid Examples
Figure 8. Cardiology Examples
Figure 9. Global Nuclear Medicine & Radiopharmaceuticals Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Nuclear Medicine & Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Nuclear Medicine & Radiopharmaceuticals Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Nuclear Medicine & Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Nuclear Medicine & Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in Nuclear Medicine & Radiopharmaceuticals: 2016 & 2020
Figure 28. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2016-2021)
Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2016-2021)
Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 34. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 35. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 36. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 37. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 38. China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 39. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 40. Japan Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 41. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 42. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 43. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 44. India Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Nuclear Medicine & Radiopharmaceuticals
Figure 47. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 48. Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed